{"id":"NCT03803475","sponsor":"Thomas Hope","briefTitle":"Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients","officialTitle":"Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-10-11","primaryCompletion":"2020-08-25","completion":"2020-08-25","firstPosted":"2019-01-14","resultsPosted":"2021-08-24","lastUpdate":"2021-08-24"},"enrollment":485,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Prostate Cancer"],"interventions":[{"type":"DRUG","name":"Ga-68 labeled PSMA-11","otherNames":["Ga-68 labeled DKFZ-PSMA-11","Ga-68 labeled Glu-NH-CO-NH- Lys(Ahx)-HBED- CC","Ga-68 labeled Glu-urea- Lys(Ahx)-HBED-CC","Ga-68 labeled HBED-CC PSMA"]},{"type":"DEVICE","name":"Positron emission tomography-computed tomography (PET/CT)","otherNames":["PET-CT"]},{"type":"DEVICE","name":"Positron emission tomography-magnetic resonance imaging (PET/MRI)","otherNames":["PET-MRI"]}],"arms":[{"label":"Ga-68 labeled PSMA-11 PET PSMA","type":"EXPERIMENTAL"}],"summary":"The investigators are imaging patients with prostate cancer using a new Positron Emission Tomography (PET) imaging agent (Ga-68-PSMA-11) in order to evaluate its ability to detect prostate cancer.","primaryOutcome":{"measure":"Detection Rate of PSMA-11 PET for Positive Disease by Prostate Specific Antigen (PSA) Group","timeFrame":"1 day","effectByArm":[{"arm":"Ga-68 Labeled PSMA-11 PET PSMA","deltaMin":0.38,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":485},"commonTop":[]}}